Epithelioid sarcoma is associated with a high percentage of SMARCB1 deletions
Open Access
- 12 October 2012
- journal article
- research article
- Published by Elsevier BV in Laboratory Investigation
- Vol. 26 (3), 385-392
- https://doi.org/10.1038/modpathol.2012.175
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Prognostic determinants in epithelioid sarcomaEuropean Journal of Cancer, 2011
- Frequent hSNF5/INI1 Germline Mutations in Patients with Rhabdoid TumorClinical Cancer Research, 2011
- Spectrum of SMARCB1/INI1 mutations in familial and sporadic rhabdoid tumorsPediatric Blood & Cancer, 2010
- Reduced expression of SMARCB1/INI1 protein in synovial sarcomaLaboratory Investigation, 2010
- Genomic Analysis Using High-Density Single Nucleotide Polymorphism-Based Oligonucleotide Arrays and Multiplex Ligation-Dependent Probe Amplification Provides a Comprehensive Analysis of INI1/SMARCB1 in Malignant Rhabdoid TumorsClinical Cancer Research, 2009
- Small cell undifferentiated variant of hepatoblastoma: Adverse clinical and molecular features similar to rhabdoid tumorsPediatric Blood & Cancer, 2009
- Loss of INI1 expression defines a unique subset of pediatric undifferentiated soft tissue sarcomasLaboratory Investigation, 2008
- Detailed analysis of 22q11.2 with a high density MLPA probe setHuman Mutation, 2007
- MLPA and MAPH: Sensitive Detection of Deletions and DuplicationsCurrent Protocols in Human Genetics, 2006
- Epithelioid sarcoma: Still an only surgically curable diseaseCancer, 2006